secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001104659-25-001341
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents opens regional sales subsidiary in Dubai, UAE
----------------------------------------------------------

- New subsidiary in Dubai Science Park will serve as a sales hub for the Middle East and Africa.
- Dr. Phillip Chan cites growing regional demand for critical care and cardiac surgery therapies.
- Subsidiary aims to strengthen existing partnerships, support customers, and drive sales growth.
- Dubai was chosen for its strategic location, strong economy, favorable tax policies, and advanced healthcare infrastructure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925001341/0001104659-25-001341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925001341/tm252036d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-001341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer